122 related articles for article (PubMed ID: 8826099)
1. Ivermectin treatment of hyperreactive onchodermatitis (sowda) in Liberia.
Darge K; Büttner DW
Trop Med Parasitol; 1995 Dec; 46(4):206-12. PubMed ID: 8826099
[TBL] [Abstract][Full Text] [Related]
2. Ivermectin treatment in severe asymmetric reactive onchodermatitis (sowda) in Sudan.
Baraka OZ; Mahmoud BM; Ali MM; Ali MH; el Sheikh EA; Homeida MM; Mackenzie CD; Williams JF
Trans R Soc Trop Med Hyg; 1995; 89(3):312-5. PubMed ID: 7660447
[TBL] [Abstract][Full Text] [Related]
3. Improvement in severe onchocercal skin disease after a single dose of ivermectin.
Pacqué M; Elmets C; Dukuly ZD; Muñoz B; White AT; Taylor HR; Greene BM
Am J Med; 1991 May; 90(5):590-4. PubMed ID: 2029016
[TBL] [Abstract][Full Text] [Related]
4. [Human onchocerciasis and "sowda" in the Republic of Yemen].
Richard-Lenoble D; al Qubati Y; Toe L; Pisella PJ; Gaxotte P; al Kohlani A
Bull Acad Natl Med; 2001; 185(8):1447-59; discussion 1459-61. PubMed ID: 11974966
[TBL] [Abstract][Full Text] [Related]
5. Mast cells in onchocercomas from patients with hyperreactive onchocerciasis (sowda).
Korten S; Wildenburg G; Darge K; Büttner DW
Acta Trop; 1998 Jun; 70(2):217-31. PubMed ID: 9698269
[TBL] [Abstract][Full Text] [Related]
6. Ivermectin treatment of onchocercal skin lesions: observations from a placebo-controlled, double-blind trial in Malawi.
Burnham G
Am J Trop Med Hyg; 1995 Mar; 52(3):270-6. PubMed ID: 7694970
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.
Albiez EJ; Newland HS; White AT; Kaiser A; Greene BM; Taylor HR; Büttner DW
Trop Med Parasitol; 1988 Mar; 39(1):19-24. PubMed ID: 3291074
[TBL] [Abstract][Full Text] [Related]
8. Onchocerciasis situation in the Tukuyu focus of southwest Tanzania after ten years of ivermectin mass treatment.
Mweya CN; Kalinga AK; Kabula B; Malley KD; Ruhiso MH; Maegga BT
Tanzan Health Res Bull; 2007 Sep; 9(3):174-9. PubMed ID: 18087895
[TBL] [Abstract][Full Text] [Related]
9. The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole.
Awadzi K; Addy ET; Opoku NO; Plenge-Bönig A; Büttner DW
Trop Med Parasitol; 1995 Dec; 46(4):213-20. PubMed ID: 8826100
[TBL] [Abstract][Full Text] [Related]
10. Onchocerciasis and human immunodeficiency virus in western Uganda: prevalences and treatment with ivermectin.
Fischer P; Kipp W; Kabwa P; Buttner DW
Am J Trop Med Hyg; 1995 Aug; 53(2):171-8. PubMed ID: 7677220
[TBL] [Abstract][Full Text] [Related]
11. [Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
Ducorps M; Gardon-Wendel N; Ranque S; Ndong W; Boussinesq M; Gardon J; Schneider D; Chippaux JP
Bull Soc Pathol Exot; 1995; 88(3):105-12. PubMed ID: 8555762
[TBL] [Abstract][Full Text] [Related]
12. Lymph nodes of onchocerciasis patients after treatment with ivermectin: reaction of eosinophil granulocytes and their cationic granule proteins.
Wildenburg G; Darge K; Knab J; Tischendorf FW; Bonow I; Büttner DW
Trop Med Parasitol; 1994 Jun; 45(2):87-96. PubMed ID: 7939167
[TBL] [Abstract][Full Text] [Related]
13. Chemokines in onchocerciasis patients after a single dose of ivermectin.
Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
[TBL] [Abstract][Full Text] [Related]
14. [Onchodermatitis (sowda) in patients in Yémen. Clinical and histologic course after treatment with ivermectin].
al Qubati Y; Reynouard F; Kumar F; Gaxotte P; Richard-Lenoble D
Sante; 1997; 7(6):391-5. PubMed ID: 9503497
[TBL] [Abstract][Full Text] [Related]
15. Immune responses directed against microfilariae correlate with severity of clinical onchodermatitis and treatment history.
Ali MM; Baraka OZ; AbdelRahman SI; Sulaiman SM; Williams JF; Homeida MM; Mackenzie CD
J Infect Dis; 2003 Feb; 187(4):714-7. PubMed ID: 12599094
[TBL] [Abstract][Full Text] [Related]
16. Migration and death of skin-dwelling Onchocerca volvulus microfilariae after treatment with ivermectin.
Duke BO; Soula G; Zea-Flores G; Bratthauer GL; Doumbo O
Trop Med Parasitol; 1991 Mar; 42(1):25-30. PubMed ID: 2052852
[TBL] [Abstract][Full Text] [Related]
17. A Reevaluation of the Tolerability and Effects of Single-Dose Ivermectin Treatment on Onchocerca volvulus Microfilariae in the Skin and Eyes in Eastern Ghana.
Opoku NO; Gyasi ME; Doe F; Lew D; Hong AR; Chithenga S; Fischer PU; King CL; Weil GJ
Am J Trop Med Hyg; 2021 Nov; 106(2):740-745. PubMed ID: 34844204
[TBL] [Abstract][Full Text] [Related]
18. Immunohistological and electron microscopic studies of microfilariae in skin and lymph nodes from onchocerciasis patients after ivermectin treatment.
Darge K; Lucius R; Monson MH; Behrendsen J; Büttner DW
Trop Med Parasitol; 1991 Dec; 42(4):361-7. PubMed ID: 1796234
[TBL] [Abstract][Full Text] [Related]
19. Ivermectin in human onchocerciasis: a clinical-pathological study of skin lesions before and three days after treatment.
Vuong PN; Traoré S; Wanji S; Diarrassouba S; Balaton A; Bain O
Ann Parasitol Hum Comp; 1992; 67(6):194-6. PubMed ID: 1301733
[TBL] [Abstract][Full Text] [Related]
20. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
